13F

Stock

InMed Pharmaceuticals Inc.

INM · held by 9 managers

Reported value

$193K

Holders

9

+4 new · −2 exited

Holders’ est. mark

−$84K

Price effect on 5 books still in the name

Largest holder

$142K

SABBY MANAGEMENT, LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
SABBY MANAGEMENT, LLC220.3K$142K−$83.7KCut−$71.7K
Citadel47K$30.3KNew
TWO SIGMA SECURITIES, LLC18.7K$12.1KNew
UBS Group AG8.07K$5.2K−$157Added$4.8K
Private Wealth Management Group, LLC5K$3.23KNew
SBI Securities Co., Ltd.300$193−$125Cut−$125
Virtu Financial LLC20K$13New
Federation des caisses Desjardins du Quebec2$2$0Held
Banque Cantonale Vaudoise6$0$0Held

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.